Safety · HRT
HRT side effects: what's normal and what's not
Most HRT side effects are mild, self-limited, and appear in the first 8 weeks as your body recalibrates. A few side effects warrant attention. Knowing the difference means you stay on treatment long enough to feel the benefits — instead of stopping too early because of an expected adjustment symptom.
Common and self-limited (4–8 weeks)
- Breast tenderness
- Mild bloating and water retention
- Occasional light spotting
- Mild nausea (usually with oral progesterone; take with food)
- Progesterone sedation (usually a feature at bedtime)
Warrants adjustment
- Persistent breast tenderness past 8 weeks (reduce estrogen dose)
- Persistent bloating (switch progesterone route or type)
- Bleeding still occurring at 6 months (investigate)
- Headaches worsening (switch to continuous transdermal)
Warrants immediate attention
- Chest pain or shortness of breath
- One-sided leg swelling or pain
- Sudden severe headache
- Sudden vision changes
- Heavy or prolonged vaginal bleeding
Frequently asked questions
What are the most common HRT side effects?
Breast tenderness, mild bloating, occasional spotting, and (with oral progesterone) mild sedation. Most resolve in 4–8 weeks.
Is spotting on HRT normal?
In the first 3–6 months, yes — especially on continuous combined therapy. Persistent bleeding after 6 months warrants ultrasound and endometrial biopsy.
What if progesterone makes me sedated?
Take micronized progesterone at bedtime with food. Sedation is often desirable then. If problematic, discuss vaginal progesterone or Mirena IUD.
What are serious side effects to watch for?
Chest pain, one-sided leg swelling or pain (possible clot), new severe headache, sudden vision changes. Stop HRT and seek immediate care.
When should I contact my clinician?
Persistent side effects beyond 8 weeks, unexplained bleeding after 6 months, or any of the above serious symptoms.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.